Study identity card

THALASSA

Spain
Share
  • Disease: Post-COVID-19
  • Study type: Randomised Clinical Trial
  • Study type descriptors: Interventional, Single centre
  • Study aim: To assess the safety and efficacy of plitidepsin as a potential treatment for long COVID
  • Number of participants enrolled: Enrollment ongoing
  • Study enrolling from to
  • Study includes follow-up for 3 months

Study Data

  • General population
  • Elderly
  • Adult
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Plitidepsin
  • Antineoplastic agent

Other information

If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it

The data is updated up to